Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Baird Maintains Outperform on Doximity, Lowers Price Target to $45

Baird analyst Vikram Kesavabhotla maintains Doximity (NYSE:DOCS) with a Outperform and lowers the price target from $68 to $45.

byBenzinga Newsdesk

May 18, 2022

1 minute read

Baird analyst Vikram Kesavabhotla maintains Doximity (NYSE:DOCS) with a Outperform and lowers the price target from $68 to $45.

Wells Fargo Maintains Overweight on Celanese, Raises Price Target to $140

By Benzinga Newsdesk

Today, 10:27 PM

Wells Fargo analyst Michael Sison maintains Celanese (NYSE:CE) with a Overweight and raises the price target from $115 to $140.

Here’s How Much $100 Invested In Anthem 5 Years Ago Would Be Worth Today

By Benzinga Insights

Today, 10:27 PM

Anthem (NYSE:ANTM) has outperformed the market over the past 90 days by 9.28%, generating a 12.1% return for its investors over the time period. Now, given this information, it may seem like price appreciation alone is the best way to have made money on this stock, that's not actually the case.

ANTM